Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 7,376 | 18,904 | 9,666 | 5,145 | 11,686 |
| Cost of Goods | 3,080 | 228 | N/A | N/A | N/A |
| Gross Profit | 4,296 | 18,676 | 9,666 | 5,145 | 11,686 |
| Operating Expenses | 71,908 | 92,185 | 125,381 | 82,975 | 94,684 |
| Operating Income | -67,532 | -73,281 | -115,715 | -77,830 | -82,998 |
| Interest Expense | 2,580 | 624 | 0 | 0 | 0 |
| Other Income | 27 | 1,747 | 963 | 350 | -191 |
| Pre-tax Income | -70,085 | -72,158 | -114,752 | -77,480 | -83,189 |
| Net Income Continuous | -70,085 | -72,158 | -114,752 | -77,480 | -83,189 |
| Net Income | $-70,085 | $-72,158 | $-114,752 | $-77,480 | $-83,189 |
| EPS Basic Total Ops | -22.85 | -27.48 | -52.60 | -42.20 | -47.20 |
| EPS Basic Continuous Ops | -22.85 | -27.48 | -52.66 | -42.22 | -47.18 |
| EPS Diluted Total Ops | -22.85 | -27.48 | -52.60 | -42.20 | -47.20 |
| EPS Diluted Continuous Ops | -22.85 | -27.48 | -52.66 | -42.22 | -47.18 |
| EPS Diluted Before Non-Recurring Items | -22.85 | -27.40 | -52.60 | -42.20 | -47.20 |
| EBITDA(a) | $-66,899 | $-72,705 | $-115,284 | $-77,548 | $-82,711 |